{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:15:44Z","timestamp":1784193344560,"version":"3.55.0"},"reference-count":11,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4771,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1996,4]]},"abstract":"<jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Im Rahmen einer Pilotstudie sowie einer deutschen multizentrischen Studie wurden 40 AIDS\u2010Patienten mit Fluconazol\u2010resistenter oropharyngealer <jats:italic>Candida<\/jats:italic>\u2010Infektion mit Itraconazol\u2010Suspension (200\u2013800 mg\/Tag) oral behandelt. Bei 39\/40 Patienten konnte initial eine Heilung oder deutliche Besserung erzielt werden. Im Gegensatz zum guten klinischen Behandlungsergebnis fanden sich jedoch nur bei 6 Patienten eine komplette Keimelimination in den Mundsp\u00fclwasserproben, bei 29 Patienten kulturell eine Keimzahlreduktion \u2010 allerdings nicht unter 10<jats:sup>2<\/jats:sup>KBE\/ml (koloniebildende Einheiten pro ml) \u2010 und bei 4 Patienten unver\u00e4ndert hohe Keimzahlen. Als Haupterreger wurde <jats:italic>C. albicans<\/jats:italic> isoliert. Auch bei Langzeitanwendung war die Itraconazol\u2010Suspension gut vertr\u00e4glich; nur bei 2 Patienten mu\u00dfte die Therapie wegen Transaminasenanstieg vorzeitig abgebrochen werden. Es fanden sich erhebliche individuelle Schwankungen der Itraconazol\u2010 bzw. Hydroxy\u2010Itraconazol\u2010Serumkonzentrationen, die nur in geringem Ausma\u00df mit den klinischen und mykologischen Behandlungsergebnissen korrelierten. Die orale Applikation von Itraconazol in fl\u00fcssiger Form f\u00fchrt durch die gleichzeitige lokale und systemische Wirksamkeit (duales Therapiekonzept) zu einer Wirkungssteigerung. Itraconazol\u2010Suspension ist bei Fluconazol\u2010Versagen eine wertvolle Alternative zur nebenwirkungsreichen Therapie mit Amphotericin B.<\/jats:p><jats:p><jats:bold>Summary. <\/jats:bold> Forty AIDS patients suffering from fluconazole\u2010resistant oropharyngeal candidosis were treated with oral itraconazole solution (200\u2013800 mg\/day). In 39\/49 patients the disease could be initially cured or significantly improved. In contrast to the good clinical results, however, only in six patients a yeast count reduction was observed, and in four patients unchanged high yeast counts persisted. The main pathogen was <jats:italic>C. albicans.<\/jats:italic> Even in longtime treatment itraconazole solution was well tolerated. In two patients only the therapy had to be stopped due to the increase of transaminases. Considerable individual deviations in serum concentrations of itraconazole or hydroxy\u2010itraconazole, respectively, were observed which correlated only to a minor degree with clinical and mycological results. Application of itraconazole in a soluble preparation caused an increase in efficacy due to simultaneous local and systemic action. In the case of resistance to fluconazole the itraconazole solution is a valuable alternative to the administration of amphotericin B which is rich in adverse reactions.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1996.tb00514.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:37:15Z","timestamp":1240591035000},"page":"102-106","source":"Crossref","is-referenced-by-count":32,"title":["Itraconazol\u2010Suspension in der Behandlung HIV\u2010infizierter Patienten mit Fluconazol\u2010resistenter oropharyngealer <i>Candida<\/i>\u2010Infektion und Soor\u00f6sophagitis"],"prefix":"10.1111","volume":"39","author":[{"given":"M.","family":"Eichel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Just\u2010N\u00fcbling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilke Brigitte","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Stille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Adamskih H. Michelet C. Guiguen C. Chevrier S. Dupont B. Cartier F.(1993)Relapses of oral candidiasis in HIV infected patients under fluconazole prophylaxis. Int. Conference on AIDS Berlin 1993 Abstract PO\u2010BO 9\u20131385."},{"key":"e_1_2_1_3_2","unstructured":"Baily G. G. Perry F. M. Denning D. W. Mandal B. K.(1993)Fluconazole resistant candidiasis in an HIV cohort. Int. Conference on AIDS Berlin 1993 Abstract PO\u2010BO 9\u20131375."},{"issue":"13","key":"e_1_2_1_4_2","first-page":"39","article-title":"Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata","volume":"18","author":"Kerridge D.","year":"1989","journal-title":"J. Antimicrobiol. Chemotherapy"},{"key":"e_1_2_1_5_2","first-page":"204","article-title":"Candida albicans resistance in AIDS","volume":"22","author":"Kitchen V. S.","year":"1991","journal-title":"J. Infect. Dis."},{"key":"e_1_2_1_6_2","unstructured":"Manteaux A. Asfeld L. Drobacheff C.et al.(1993)Fluconazole resistant oral candidiasis in HIV positive patients. Int. Conference on AIDS Berlin 1993 Abstract PO\u2010BO 9\u20131401."},{"key":"e_1_2_1_7_2","unstructured":"Newman S. Fisher A. Rinaldi M.et al.(1993)Clinically significantCandidamucositis resistant to high dose fluconazole in patients with AIDS. Int. Conference on AIDS. Berlin 1993 Abstract PO\u2010BO 9\u20131372."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.9.2092-2098.1994"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01992164"},{"key":"e_1_2_1_10_2","unstructured":"Cartledge J. D. Midgley J. Youle M. et al.(1993)The use of cyclodextrin solution fomulation of itraconazole to treat candidiasis unresponsive to other azoles preparations in patients with AIDS. Int. Conference on AIDS Berlin 1993 Abstract WS B 12\u20132."},{"issue":"7","key":"e_1_2_1_11_2","first-page":"19","article-title":"Resistant trends in oral Candida infections: \u201cThe clinical challenge","volume":"11","author":"Dupont B.","year":"1993","journal-title":"Clinician"},{"issue":"2","key":"e_1_2_1_12_2","first-page":"56","article-title":"Die Therapie der Candidose und Cryptococcose bei AIDS","volume":"37","author":"Just\u2010N\u00fcbling G.","year":"1994","journal-title":"Mycoses"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1996.tb00514.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1996.tb00514.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T12:25:04Z","timestamp":1695817504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1996.tb00514.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":11,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["10.1111\/j.1439-0507.1996.tb00514.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1996.tb00514.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}